Covered recipient · General Payments record
JAMES MOFFITT
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$558.21
- Reported across 34 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $169.10 | 10 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $67.57 | 4 |
| Lilly USA, LLC | $32.63 | 2 |
| Insulet Corporation | $20.93 | 1 |
| ABBVIE INC. | $20.84 | 1 |
| Acerta Pharma LLC | $13.61 | 1 |
| Abbott Laboratories | $13.52 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (10)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $13.52 | 06/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124997619 | CMS |
| ABBVIE INC. | $20.84 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105050122 | CMS |
| AstraZeneca Pharmaceuticals LP | $13.61 | 03/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104248197 | CMS |
| Insulet Corporation | $20.93 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116803442 | CMS |
| Lilly USA, LLC | $17.12 | 04/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135048302 | CMS |
| Lilly USA, LLC | $15.51 | 04/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135025772 | CMS |
| Novo Nordisk Inc | $17.81 | 04/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096610856 | CMS |
| Novo Nordisk Inc | $15.49 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097122910 | CMS |
| Novo Nordisk Inc | $16.35 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097346470 | CMS |
| Novo Nordisk Inc | $17.92 | 08/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097512831 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2020, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.